Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News THC Farmaceuticals Inc CBDG

Healthcare Industrials Biotechnology
THC Farmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. It offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive... see more

Recent & Breaking News (OTCPK:CBDG)

    Legendary Hero Senator Mike Gravel Ended Final Career As Chairman and CEO of THC Farmaceuticals, Inc When He Passed Away This Weekend

    GlobeNewswire June 28, 2021

    THC Farmaceuticals, Inc. Acquires Controlling Interest in G.K. Manufacturing from Cannabis Sativa, Inc.

    GlobeNewswire May 4, 2021

    DR. RUBIN'S ANXIETY PILL MADE OF CANNABIS TO HIT THE MARKET NEXT WEEK

    GlobeNewswire December 7, 2020

    CBDual Biotechnology Corp (subsidiary of OTC: CBDG) to Offer ORALDNA(R) Testing to Improve Oral and Systemic Health

    Accesswire August 9, 2019

    THC Farmaceuticals Receives Patent Protection in Republic of South Africa For Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants

    Accesswire June 12, 2019

    THC Farmaceuticals Acquires Fifty Percent Interest In 78 Acres of California Land; Through Subsidiary CBDual Biotech Begins Retailing Charlotte’s Web CBD Rich Products; To Begin Clinical Trials

    Accesswire March 6, 2019

    THC Farmaceuticals Completes Acquisition of Majority Ownership of CBDual Biotechnology Corp; Applies for Provisional Patent

    Accesswire October 17, 2018

    THC Farmaceuticals Signs Contract to Acquire CBDual Biotechnology

    Accesswire August 22, 2018

    THC Farmaceuticals, Inc. Announces the Hiring of Ed Rosenthal as President

    Accesswire June 9, 2015

    THC Farmaceuticals Announces Appointment of Former U.S. Senator Mike Gravel as Chief Executive Officer and Chairman of the Board

    Accesswire June 1, 2015

    City Media Name Change to THC Farmaceuticals Completed

    Accesswire May 22, 2015

    City Media Announces Name Change to THC Farmaceuticals Approved, Reflecting Core Operations Commitment

    Accesswire April 15, 2015